David van de Vijver
David van de Vijver
Department of virology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
Verified email at erasmusmc.nl - Homepage
TitleCited byYear
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
8202009
Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets
VJ Munster, E de Wit, JMA van den Brand, S Herfst, EJA Schrauwen, ...
Science 325 (5939), 481-483, 2009
6722009
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ...
The Journal of infectious diseases 192 (6), 958-966, 2005
5202005
An automated genotyping system for analysis of HIV-1 and other microbial sequences
T De Oliveira, K Deforche, S Cassol, M Salminen, D Paraskevis, ...
Bioinformatics 21 (19), 3797-3800, 2005
4802005
Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures
MK Hayden, MJM Bonten, DW Blom, EA Lyle, DAMC van de Vijver, ...
Clinical Infectious Diseases 42 (11), 1552-1560, 2006
3972006
Transmission of drug-resistant HIV-1 is stabilizing in Europe
J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ...
The Journal of infectious diseases 200 (10), 1503-1508, 2009
2632009
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS medicine 12 (4), e1001810, 2015
1752015
Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world
D Frentz, CA Boucher, DA Van De Vijver
AIDs Rev 14 (1), 17-27, 2012
1702012
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
1552014
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ...
Retrovirology 6 (1), 49, 2009
1322009
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10 (1), 7, 2013
1292013
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
DA van de Vijver, AMJ Wensing, G Angarano, B Åsjö, C Balotta, E Boeri, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (3), 352-360, 2006
1212006
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2015
932015
Stochastic simulation of HIV population dynamics through complex network modelling
PMA Sloot, SV Ivanov, AV Boukhanovsky, DAMC van de Vijver, ...
International Journal of Computer Mathematics 85 (8), 1175-1187, 2008
882008
Sustainable HIV treatment in Africa through viral load-informed differentiated care
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68, 2015
842015
Epidemiology of restless legs syndrome as diagnosed in UK primary care
DAMC van de Vijver, T Walley, H Petri
Sleep medicine 5 (5), 435-440, 2004
792004
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time
D Frentz, CAB Boucher, M Assel, A De Luca, M Fabbiani, F Incardona, ...
PloS one 5 (7), e11505, 2010
712010
Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa
RE Barth, JTM van der Meer, AIM Hoepelman, PA Schrooders, ...
European journal of clinical microbiology & infectious diseases 27 (10), 977-984, 2008
692008
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models
DAMC Van De Vijver, BE Nichols, UL Abbas, CAB Boucher, V Cambiano, ...
Aids 27 (18), 2943-2951, 2013
662013
Bacteremic Complications of Intravascular Catheters Colonized with Staphylococcus aureus
MB Ekkelenkamp, T van der Bruggen, DAMC van de Vijver, TFW Wolfs, ...
Clinical infectious diseases 46 (1), 114-118, 2008
632008
The system can't perform the operation now. Try again later.
Articles 1–20